Watch on Demand: Outsourced Pharma Capacity Update – January 2025
Get access today!
| region | na1 |
| portalId | 1769030 |
| formId | 7dfe7f53-904c-47ef-83d9-6e7fdda3dbbb |
| target | services-hubspot-form |
| redirectUrl | https://www.aldevron.com/thank-you/on-demand-opcu-alchemy-jan-2025 |
Revolutionizing mRNA Manufacturing with Alchemy™ Cell-free DNA Technology
What are the advantages of Alchemy™ Cell-free DNA technology? In an Outsourced Pharma Capacity Update (OPCU) webinar on January 30, Nate Russart, PhD, and Tanner Dockendorf explained Alchemy Cell-free DNA technology, the next-generation solution for rapid and efficient linear DNA template for mRNA manufacturing. This innovative synthetic technology revolutionizes the production of linear DNA using an enzymatic process, cutting production timelines by over 50%.
In this session, you will discover how Alchemy technology utilizes a cell-free, enzymatic DNA manufacturing process that accelerates linDNA template production, allowing you to expedite your mRNA research and development pipeline.
Key Highlights
- Accelerated Production: Reduces linDNA template production timelines by half, enabling faster mRNA synthesis.
- Enhanced Purity: Eliminates bacterial cells from the amplification process, resulting in cleaner linear DNA templates free from host cell contaminants.
- Industry-leading Efficiency: Produces high-quality linear DNA templates swiftly and reliably.
- Comparable Activity: Comparable to traditional linear plasmid DNA templates, ensuring consistency and reliability in mRNA production.